Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs

This publication has 34 references indexed in Scilit:

• Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial
  The Lancet, 2007
• Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors
  American Journal of Gastroenterology, 2006
• Prevention of anti‐inflammatory drug‐induced gastrointestinal damage: Benefits and risks of therapeutic strategies
  Annals of Medicine, 2006
• Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications
  The American Journal of Medicine, 2005
• Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial
  Alimentary Pharmacology & Therapeutics, 2003
• Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis
  New England Journal of Medicine, 2002
• Preventing Recurrent Upper Gastrointestinal Bleeding in Patients withHelicobacter pyloriInfection Who Are Taking Low-Dose Aspirin or Naproxen
  New England Journal of Medicine, 2001
• Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient
  Gastroenterology, 2001
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs
  Annals of Internal Medicine, 1995
• Dyspepsia in NSAID Users
  Journal of Clinical Gastroenterology, 1989